These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8649850)

  • 21. SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells.
    Yiu GK; Chan WY; Ng SW; Chan PS; Cheung KK; Berkowitz RS; Mok SC
    Am J Pathol; 2001 Aug; 159(2):609-22. PubMed ID: 11485919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cytokines and receptors in normal, immortalized, and malignant ovarian epithelial cell lines.
    Bandera CA; Tsui HW; Mok SC; Tsui FW
    Anticancer Res; 2003; 23(4):3151-7. PubMed ID: 12926048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression.
    Coppola D; Saunders B; Fu L; Mao W; Nicosia SV
    Cancer Res; 1999 Jul; 59(13):3264-70. PubMed ID: 10397275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of secreted protein acidic and rich in cysteine during adipose conversion and adipose tissue hyperplasia.
    Chavey C; Boucher J; Monthouël-Kartmann MN; Sage EH; Castan-Laurell I; Valet P; Tartare-Deckert S; Van Obberghen E
    Obesity (Silver Spring); 2006 Nov; 14(11):1890-7. PubMed ID: 17135603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27.
    Acquati F; Morelli C; Cinquetti R; Bianchi MG; Porrini D; Varesco L; Gismondi V; Rocchetti R; Talevi S; Possati L; Magnanini C; Tibiletti MG; Bernasconi B; Daidone MG; Shridhar V; Smith DI; Negrini M; Barbanti-Brodano G; Taramelli R
    Oncogene; 2001 Feb; 20(8):980-8. PubMed ID: 11314033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential gene expression between normal and tumor-derived ovarian epithelial cells.
    Ismail RS; Baldwin RL; Fang J; Browning D; Karlan BY; Gasson JC; Chang DD
    Cancer Res; 2000 Dec; 60(23):6744-9. PubMed ID: 11118061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes.
    Watkins G; Douglas-Jones A; Bryce R; Mansel RE; Jiang WG
    Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):267-72. PubMed ID: 15763438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
    Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW
    Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of SPARC in murine lens epithelium leads to increased deposition of laminin-1 in lens capsule.
    Yan Q; Perdue N; Blake D; Sage EH
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4652-60. PubMed ID: 16303962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice.
    Collinet P; Vereecque R; Sabban F; Vinatier D; Leblanc E; Narducci F; Querleu D; Quesnel B
    J Obstet Gynaecol Res; 2006 Oct; 32(5):449-53. PubMed ID: 16984510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma-Linolenic acid regulates the expression and secretion of SPARC in human cancer cells.
    Watkins G; Martin TA; Bryce R; Mansel RE; Jiang WG
    Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):273-8. PubMed ID: 15763439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
    Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
    Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
    Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
    Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics].
    Ruan HY; Li DR; Li L; Guan X; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):482-6. PubMed ID: 17961340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Syed V; Zhang X; Lau KM; Cheng R; Mukherjee K; Ho SM
    Oncogene; 2005 Dec; 24(55):8128-43. PubMed ID: 16116479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.
    Sato N; Fukushima N; Maehara N; Matsubayashi H; Koopmann J; Su GH; Hruban RH; Goggins M
    Oncogene; 2003 Aug; 22(32):5021-30. PubMed ID: 12902985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibitory effect of breast cancer metastasis suppressor l gene on metastasis of human ovarian cancer cell in vitro and in vivo].
    Jiang J; Xia M; Feng JB; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):398-402. PubMed ID: 17697602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPARC enhances tumor stroma formation and prevents fibroblast activation.
    Chlenski A; Guerrero LJ; Yang Q; Tian Y; Peddinti R; Salwen HR; Cohn SL
    Oncogene; 2007 Jul; 26(31):4513-22. PubMed ID: 17260013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL.
    Syed V; Ho SM
    Oncogene; 2003 Oct; 22(44):6883-90. PubMed ID: 14534535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis.
    Koblinski JE; Kaplan-Singer BR; VanOsdol SJ; Wu M; Engbring JA; Wang S; Goldsmith CM; Piper JT; Vostal JG; Harms JF; Welch DR; Kleinman HK
    Cancer Res; 2005 Aug; 65(16):7370-7. PubMed ID: 16103089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.